Expert Report: Total Delaware Qualified Research and Development Expenses and the Strategic R&D Tax Credit

I. Executive Summary: The Strategic Value of the Delaware R&D Tax Credit

Total Delaware Qualified Research and Development Expenses (Delaware QREs) are those expenditures meeting the federal definition of Qualified Research Expenses (IRC § 41) that are incurred specifically for qualified research activities performed within the State of Delaware. These localized, geographically-specific expenses serve as the sole foundation for calculating the state’s highly beneficial, fully refundable R&D tax credit.

Detailed Analysis of the Delaware R&D Credit

The State of Delaware provides a compelling and financially advantageous tax incentive under Del. Code Ann. tit. 30, Chapter 20, Subchapter VIII, specifically codified in § 2070, designed to stimulate and reward innovation conducted within its geographical boundaries.1 This program holds a significant competitive edge over many state R&D tax credit regimes primarily because the Delaware credit is fully refundable.3 The distinction of refundability means that if the calculated credit amount exceeds the taxpayer’s state income tax liability, the unused portion is returned as a cash refund, shifting the benefit from a mere liability offset to a direct boost to corporate cash flow.

Delaware QREs form the quantifiable basis for this credit and dictate eligibility under the program’s dual-path structure. Taxpayers can annually elect between two distinct calculation methodologies: the Base Amount Method (offering a 10% or 20% credit on excess QREs) or the Apportioned Alternative Simplified Credit (ASC) Method (offering 50% or 100% of the apportioned federal credit).1 The value of the credit is substantial, particularly following legislative changes that removed the previous $5 million annual cap 3, ensuring that even large, R&D-intensive firms can receive the full value of their eligible expenses.

A key strategic feature of the Delaware statute is the requirement for an annual, independent election 2 of the credit determination method. This provision grants taxpayers the critical flexibility to choose the method—Method 1 (Base Amount) or Method 2 (Apportioned ASC)—that yields the highest state credit for any given tax year, irrespective of the method selected for the related federal R&D tax credit calculation. This ability to optimize the state benefit year over year is an indispensable tool for maximizing tax efficiency based on evolving R&D expenditure patterns and historical base amounts. The combined effect of full refundability and the elimination of prior limitations ensures that the Delaware R&D credit regime remains highly attractive, providing significant capital to both nascent, pre-revenue technology firms and established enterprises alike.

II. Defining Total Delaware Qualified Research and Development Expenses (Delaware QREs)

The technical definition of Delaware QREs is a synthesis of federal substantive law concerning the nature of the research activity and strict state law concerning the geographical location where that activity occurs.

II.A. The Foundational Nexus with Federal Law (IRC § 41)

Delaware law relies heavily on the definitions established within the Internal Revenue Code (IRC) § 41, the federal credit for increasing research activities. Specifically, Del. Code Ann. tit. 30, § 2071, ensures definitional harmony, stating that “Any term used in this subchapter shall have the same meaning as when used in a comparable context in the Internal Revenue laws of the United States, unless a different meaning is clearly required”.2

To qualify for the Delaware credit, the underlying activities must first satisfy the rigorous federal four-part test for Qualified Research. This research must be technological in nature, designed to achieve a new or improved business component, involve a process of experimentation, and must be undertaken for the purpose of discovering information.5

Once the activity is federally qualified, the expenses incurred fall into three permissible categories of Qualified Research Expenses (QREs) under the IRC 5:

1. In-House Research Expenses (Wages): This includes wages paid to employees for conducting qualified services, such as engaging directly in qualified research, directly supervising qualified research, or directly supporting qualified research.6
2. Supplies: Costs related to tangible property consumed in the research process, provided they are not land or improvements to land.6
3. Contract Research Expenses: Generally limited to 65% of amounts paid or incurred to third-party contractors for performing qualified research.

Any R&D activity performed in Delaware that meets these federal standards automatically qualifies for the Delaware credit, assuming the geographic nexus is satisfied.4

II.B. The Critical Concept of Geographic Qualification (§ 2072)

The explicit inclusion of the term “Delaware” in Delaware QREs necessitates that the qualified activities be physically performed within the state’s borders. This geographic nexus is the distinguishing factor for state eligibility. Delaware Code Title 30, § 2072, “Determination of qualified research and development expenses,” directly addresses this requirement.2

Section 2072 grants the Director of the Division of Revenue (DOR) substantial regulatory oversight, stating that the Director may consider “the location where the services are performed and other factors that the Director within the Director’s sound discretion reasonably determines are relevant for the determination”.8 This language places significant importance on auditable proof of physical activity.

For multi-state taxpayers, the administrative focus shifts from merely proving the research is qualified (the federal hurdle) to proving where the research occurred (the Delaware hurdle). The reliance on the physical location where services are performed mandates rigorous adherence to allocation standards and comprehensive documentation. Taxpayers operating across state lines must track which specific employees performed qualified services while physically present in Delaware. This means that a company cannot simply rely on its corporate headquarters being registered in Delaware; rather, it must maintain meticulous time and location records for its R&D staff, aligning payroll allocations directly with in-state R&D performance.

This geographical constraint is particularly pertinent in the modern context of remote or hybrid work arrangements. If an R&D employee resides outside Delaware but is occasionally directed to perform qualified research in a Delaware facility, only the wages attributable to the time spent physically within the state conducting the qualified activity count toward Delaware QREs. The statute thus elevates the documentation standard, requiring a detailed nexus study to substantiate the physical location of labor, supplies, and contract work to satisfy the DOR’s potential scrutiny regarding the Director’s discretionary determination authority.8

III. Statutory Framework and Calculation Mechanics

The Delaware R&D tax credit is computed by electing one of two methodologies, which differ in their reliance on historical data versus current federal credit computations. This choice is made annually and independently of the federal election.2

III.A. Summary of Credit Calculation Methods

The statutory framework provides enhanced credit rates for small businesses, which are defined as any taxpayer with average annual gross receipts, as determined by IRC § 41(c)(1)(B), not exceeding $20,000,000.1

Table 1: Delaware R&D Tax Credit Calculation Rate Summary

III.B. Calculation Method 1: The Base Amount Method

The first method is designed to reward the increase, or excess, of current-year Delaware QREs compared to a historical baseline, known as the Delaware Base Amount.2 The credit calculation uses the formula:

$$\text{Credit} = \text{Rate} \times (\text{Total Delaware QREs} – \text{Delaware Base Amount})$$

For standard taxpayers, the credit rate is 10% of the excess amount. For qualifying small businesses, the incentive is doubled, applying a 20% rate to the excess.1 This method demands significant historical data to calculate the base amount, as detailed in Section IV.

III.C. Calculation Method 2: Apportioned Federal Alternative Simplified Credit (ASC)

The second method ties the state credit directly to the federal R&D tax credit calculated using the Alternative Simplified Credit (ASC) method under IRC § 41(c)(5).2 This approach simplifies the historical data requirement by relying primarily on the current federal calculation and the localization of QREs.

The crucial determination under this method is calculating Delaware’s apportioned share of the federal credit. This is achieved by multiplying the federal ASC by a ratio that reflects the proportion of R&D activity performed in Delaware relative to the taxpayer’s total national R&D activity 2:

$$\text{Apportioned Share} = \text{Federal ASC} \times \frac{\text{Delaware QREs}}{\text{Total Qualified Research and Development Expenses}}$$

The rate applied to this apportioned share is 50% for standard taxpayers and, critically, is boosted to 100% for small businesses.1 The provision allowing a small business to claim 100% of the apportioned federal credit creates a powerful economic advantage, especially for companies with a high concentration of R&D activity within Delaware. If a small business performs all its qualified research within the state, its Delaware QREs will equal its total QREs, resulting in a 100% apportionment ratio. Consequently, the state benefit in this scenario is effectively a dollar-for-dollar match of the federal credit, providing a cumulative incentive that is highly competitive on a national scale.

It is necessary for taxpayers utilizing the small business enhancement to adhere strictly to the gross receipts definition set forth in the Delaware Code, specifically requiring annual gross receipts not in excess of $20,000,000, regardless of the calculation method chosen for the federal credit.1 This ensures that the heightened state incentive is reserved exclusively for truly smaller enterprises, preventing unintended use by larger firms that might otherwise qualify for the federal ASC.

IV. Calculating the Delaware Base Amount: A Detailed Mechanism

For taxpayers electing Method 1, the determination of the Delaware Base Amount is complex, requiring precise historical data tracking of both qualified expenses and apportioned sales over a four-year lookback period.

IV.A. Methodology and Components

The Delaware Base Amount is calculated by multiplying the taxpayer’s Fixed-Base Percentage (FBP) by the Average Annual Gross Receipts (AAGR) for the four taxable years preceding the credit year.7

The Fixed-Base Percentage (FBP) is defined as the ratio of Delaware QREs to Delaware Gross Receipts for the four preceding years.7 If the taxpayer has fewer than four years of data, the available years are used; if no such data exists, the FBP is zero.

The Average Annual Gross Receipts (AAGR) represents the average of the Delaware apportioned gross receipts for the four immediately preceding taxable years.7

IV.B. Apportionment of Gross Receipts

The AAGR component requires the use of gross receipts determined under Delaware’s specific apportionment rules. The Code specifies that these gross receipts must follow Delaware apportionment rules and are not restricted solely to sales delivered within Delaware.7 This necessitates consistency: the gross receipts figure used for the R&D base amount calculation must align with the methodology employed for general corporate income tax liability determination in the state. For multi-state corporations, this linkage ensures the base is accurately weighted to reflect the overall business activity presence in Delaware.

IV.C. The 50% Minimum Threshold

A critical constraint is imposed on the final Delaware Base Amount calculation to ensure the credit remains an incentive for incremental growth. Regardless of the FBP calculation, the resulting Delaware Base Amount cannot be less than 50% of the current taxable year’s Total Delaware QREs.7

This threshold establishes a floor. Companies that are relatively new to R&D activity in Delaware, or those experiencing rapid, recent expansion, may calculate a historically low FBP, potentially resulting in a mathematically low base amount. However, the 50% minimum ensures that, at best, only half of the current-year Delaware QREs can qualify for the credit under Method 1 (since the base covers the first half of the expenses).

The intricacy of Method 1—which relies heavily on five years of historical, geographically delimited data—makes it generally more complex and often more volatile than Method 2, which depends primarily on a single-year concentration ratio. Companies must perform continuous analysis; for instance, a company undergoing significant growth in R&D may find Method 1 advantageous due to its low historical base, maximizing the “excess QREs.” Conversely, a stable company, whose historical QREs may push the base near or above the 50% floor, might yield a greater credit under Method 2. This difference in dependence on historical versus current metrics mandates careful annual evaluation of both methodologies.

V. State Revenue Office Guidance and Compliance Procedures

The Division of Revenue (DOR) governs the administrative process for claiming the Delaware R&D credit, requiring specific applications and adhering to strict deadlines to ensure compliance.

V.A. Key Administrative Forms and Deadlines

Taxpayers seeking the credit must navigate a specialized compliance process that begins with the submission of a formal application. The required documentation is Form 2071AC, titled the “Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits”.9

A critical procedural aspect is the filing deadline: Form 2071AC must be completed and submitted to the Delaware Division of Revenue on or before September 15th following the end of the taxable year during which the qualified R&D expenses were incurred.4 This rigid deadline is essential for maintaining eligibility and cannot be overlooked during tax planning.

After the DOR reviews and approves the credit amount, the authorized credit is transferred to the taxpayer’s final state income tax return via specific forms 10:

• C Corporations, S Corporations, and Partnerships enter the amount on Form 700, the Delaware Income Tax Credit Schedule.9
• Individual filers and Sole Proprietors utilize Form PIT-CRS, the Delaware Income Tax Credit Schedule.10

V.B. Refundability and Pass-Through Mechanics

The fully refundable status of the credit provides significant financial relief.3 Any portion of the R&D credit that exceeds the taxpayer’s Delaware tax liability is paid out directly as a tax refund.4

For entities that do not pay corporate income tax, such as S Corporations and Partnerships, the credit is allocated to their owners based on respective ownership percentages.9 For example, a partnership multiplies the Delaware R&D credit by the percentage ownership of each partner before the partner claims the resulting amount on their personal income tax return (Form PIT-CRS).9 The fact that the credit is fully refundable ensures that the benefit flows directly to the individual owners, providing a critical injection of capital into the business’s owners and operations.

The administrative procedure involving tax credit approval from the DOR prior to filing the final income tax return 10 provides a mechanism for early review and certainty regarding the calculation methodology. This pre-approval process is valuable because it compels the taxpayer and the DOR to settle disputes concerning the underlying calculation before the ultimate filing, thereby mitigating the risk of major later adjustments focusing solely on the factual substantiation of the claimed Delaware QREs.

V.C. Audit Readiness and Location Documentation

Given the Director’s explicit authority to determine relevant factors regarding the location where services are performed (§ 2072) 8, rigorous documentation of the geographic nexus is paramount for audit defense.

Audit triggers often include inconsistencies in the claims, such as expenses that do not align with supporting documentation, or unexplained spikes in credit amounts compared to previous years.11 To counter this, taxpayers must maintain detailed records that unequivocally establish that the expenses—wages, supplies, and contract costs—were incurred for activities physically conducted within Delaware. This detailed location tracking for R&D personnel is crucial, especially for multi-state employers, as it substantiates the critical distinction between Total QREs (national) and Delaware QREs (local).

VI. Detailed Calculation Example: Strategic Application of Delaware QREs

This example demonstrates the importance of determining the correct volume of Delaware QREs and the strategic necessity of comparing the two available calculation methods to maximize the credit benefit.

Scenario: Innovate DE, LLC (Tax Year 2024)

Innovate DE, LLC is an advanced manufacturing firm considered a small business for tax purposes.

• Small Business Status: Average Annual Gross Receipts (AAGR, prior 4 years) = $15,000,000. (Qualifies for enhanced rates, as this is $\leq$ $20M).1
• Current Year (CY 2024) QRE Data:

• Total QREs (Nationwide Activity): $1,500,000
• Total Delaware QREs (In-State Activity): $1,200,000
• Federal Tentative R&D Credit (ASC Method): $140,000

• Historical Data (FBP Calculation):

• Delaware Apportioned Gross Receipts (2020–2023): $50,000,000
• Total Delaware QREs (2020–2023): $3,000,000

Step A: Method 1 Calculation (Excess QREs over Base Amount)

Method 1 uses the 20% small business rate.1

1. Fixed-Base Percentage (FBP) Calculation:
   
   $$\text{FBP} = \frac{\text{Prior 4 Yrs DE QREs}}{\text{Prior 4 Yrs DE Gross Receipts}} = \frac{\$3,000,000}{\$50,000,000} = 6.0\%$$
2. Average Annual Gross Receipts (AAGR):
   
   $$\text{AAGR} = \frac{\$50,000,000}{4} = \$12,500,000$$
3. Preliminary Delaware Base Amount:
   
   $$\text{Base} = \text{FBP} \times \text{AAGR} = 6.0\% \times \$12,500,000 = \$750,000$$
4. Applying the 50% Minimum Threshold: The base amount cannot be less than 50% of current Delaware QREs.7
   $$50\% \text{ of DE QREs} = 0.50 \times \$1,200,000 = \$600,000$$
   
   Since the Preliminary Base of $750,000$ is greater than the $600,000$ minimum, the Delaware Base Amount is $\mathbf{\$750,000}$.
5. Calculate Excess QREs:
   
   $$\text{Excess} = \text{DE QREs} – \text{DE Base Amount} = \$1,200,000 – \$750,000 = \$450,000$$
6. Calculate Credit (20% Rate):
   
   $$\text{Credit (Method 1)} = 0.20 \times \$450,000 = \mathbf{\$90,000}$$

Step B: Method 2 Calculation (Apportioned Federal ASC)

Method 2 uses the 100% small business rate.2

1. Determine Delaware QRE Apportionment Ratio: The credit is scaled by the ratio of in-state QREs to total QREs.2
   $$\text{Ratio} = \frac{\text{Delaware QREs}}{\text{Total QREs}} = \frac{\$1,200,000}{\$1,500,000} = 0.80$$
2. Calculate Delaware’s Apportioned Share of Federal ASC:
   
   $$\text{Apportioned Share} = \text{Federal ASC} \times \text{Ratio} = \$140,000 \times 0.80 = \$112,000$$
3. Calculate Credit (100% Rate):
   
   $$\text{Credit (Method 2)} = 1.00 \times \$112,000 = \mathbf{\$112,000}$$

Step C: Strategic Conclusion

In this scenario, Innovate DE, LLC should elect Method 2, yielding a fully refundable credit of $\mathbf{\$112,000}$, significantly higher than the $\$90,000$ available under Method 1.

The comparison underscores the high value placed on the concentration of R&D activity in Delaware. The 80% ratio of Delaware QREs to Total QREs, when multiplied by the generous 100% small business matching rate, proves more beneficial than the incremental reward of Method 1. This scenario demonstrates that rigorous annual modeling is essential. Had the company’s R&D been less concentrated in Delaware—for example, a 50% ratio—Method 2 would have yielded only $70,000 ($140,000 $\times$ 50%), making Method 1 the superior choice. The ongoing strategic evaluation of staffing and expenditure location directly influences the maximization of the state tax incentive.

VII. Conclusion and Strategic Implications

The Delaware R&D tax credit regime is a sophisticated, highly valuable incentive driven entirely by the definition and substantiation of Total Delaware Qualified Research and Development Expenses. These expenses, defined by both federal research criteria and strict state geographic requirements, are the primary factor in determining the ultimate financial benefit.

The analysis of the Delaware R&D credit framework reveals critical strategic imperatives for businesses operating or considering operations in the state:

1. Primacy of Geographic Nexus: The statutory requirement in § 2072 focusing on the “location where the services are performed” places a heavy documentation burden on multi-state taxpayers. Successful claims hinge on detailed records proving the physical presence of R&D activity within Delaware, a requirement the Division of Revenue is explicitly authorized to scrutinize under its “sound discretion”.8 Corporate tax planning must prioritize the verifiable allocation of employee wages and contract expenses to in-state activities to withstand audit.
2. Mandatory Annual Optimization: The availability of two distinct calculation methods, coupled with the ability to elect the highest resulting credit independently of the federal election, mandates sophisticated annual modeling. Taxpayers must rigorously compare the results of the Base Amount Method (Method 1) against the Apportioned ASC Method (Method 2), as demonstrated in the example. For small businesses, the potential to claim 100% of the apportioned federal credit often makes Method 2 the dominant choice, particularly when Delaware QRE concentration is high.
3. Focus on Cash Flow and Refundability: The fully refundable nature of the credit transforms the R&D incentive into a direct cash flow mechanism.4 For emerging technology companies, this immediate financial injection can be critical for funding ongoing research or covering operational losses. The state ensures this benefit is delivered through a formal application and approval process via Form 2071AC, requiring timely submission.
4. Adherence to Compliance Timeline: The rigid September 15th deadline for submitting Form 2071AC is essential for securing the credit.4 Compliance teams must integrate this date into their annual tax calendars, ensuring that the study quantifying Delaware QREs is completed and reviewed well in advance of the required submission date.

Ultimately, maximizing the Delaware R&D tax credit requires more than simply qualifying for the federal credit; it demands a precise, disciplined approach to documenting the geographical nexus of every expense, followed by a strategic annual computation that leverages the most advantageous rate and methodology provided by the Delaware Code.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/